Booth Bruce bought KYMR
April 22, 2026 · Form 4 insider transaction
Booth Bruce bought 5,641 shares of Kymera Therapeutics, Inc. at $14.18 per share, a transaction worth $80.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,641
Price
$14.18
Total value
$80.0K
InsiderBooth Bruce
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 22, 2026
Filing dateApril 24, 2026
Shares owned after5,641
OwnershipDirect
10b5-1 planNo
AmendedNo